Filter Results:
(2,781)
Show Results For
- All HBS Web
(6,132)
- People (19)
- News (2,164)
- Research (2,781)
- Events (3)
- Multimedia (212)
- Faculty Publications (1,947)
Show Results For
- All HBS Web
(6,132)
- People (19)
- News (2,164)
- Research (2,781)
- Events (3)
- Multimedia (212)
- Faculty Publications (1,947)
Sort by
- 10 Jan 2005
- Research & Ideas
Motivation and the Cross-Sector Alliance
potentially hazardous for human health or the environment. In this scenario, it would make sense for such a company to become part of the solution, and engage in programs aimed at solving these issues, thus the interest of the beverage... View Details
- 12 Jan 2015
- Research & Ideas
Regulators Ease Up on Companies Generating Political Benefits
choosing not to target firms that generate employment, for example, may erode investor confidence if they are found more likely to have accounting problems, leading to less investment and actually driving down employment. Similarly,... View Details
Keywords: by Michael Blanding
- 05 Nov 2001
- Research & Ideas
Venture Capital Goes Boomor Bust?
market timing was critical to the success of the new venture. In addition to providing financing and advice on product development, marketing, and finance, Kleiner introduced Netscape to key Silicon Valley players, as well as the View Details
Keywords: by Paul A. Gompers & Josh Lerner
- 10 Jan 2017
- First Look
First Look at New Research: January 10, 2017
risk changing its business model or proceed with confidence? Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/217035-PDF-ENG Harvard Business School Case 517-070 Access Health CT: Marketing Affordable View Details
Keywords: Sean Silverthorne
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- 24 Sep 2013
- First Look
First Look: September 24
matters are too long. The response of investors who say they care about sustainability-and their numbers are large and growing-is that companies do a poor job in providing them with the information they need to take sustainability into... View Details
Keywords: Sean Silverthorne
- 11 Oct 2004
- Research & Ideas
Four Ways to Create Lasting Change
Clinics in Minnesota. That effort produced enduring behavioral and cultural changes regarding an issue (medical errors) that has proven very difficult to address for many health care institutions. Moving... View Details
Keywords: by Martha Lagace
- 14 Feb 2012
- First Look
First Look: February 14
individuals bring well-articulated preexisting preferences to such decisions. Understanding beliefs and attitudes motivating these preferences can assist physicians in helping parents make informed decisions consistent with their values. Consumer-Driven View Details
Keywords: Carmen Nobel
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)
- August 2008 (Revised May 2009)
- Background Note
Note on Generic Drugs in the European Union
By: Robert C. Pozen and Elizabeth M. Leonard
Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details
Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States
Pozen, Robert C., and Elizabeth M. Leonard. "Note on Generic Drugs in the European Union." Harvard Business School Background Note 309-019, August 2008. (Revised May 2009.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- 03 Apr 2018
- First Look
New Research and Ideas, April 3, 2018
of spending on traditional aid programs in areas such as health care and food access in developing countries, GiveDirectly transfers cash directly to the poor. As experiments have shown this approach to be... View Details
Keywords: Sean Silverthorne
- 08 Dec 2009
- First Look
First Look: Dec. 8
alternative paths to career success: officers of higher initial ability are more likely to invest in skill, but caste affinity to the politician's party base also helps secure important positions. Download the paper:... View Details
Keywords: Martha Lagace
- 15 Aug 2005
- HBS Case
Classic Cases Live On at HBS
quality service, attention to patients, and an attractive work environment for doctors and staff—must be taken into account. By showing the positive impact of making health care more consumer-oriented,... View Details
Keywords: by Garry Emmons
- 16 Feb 2012
- Op-Ed
Nitin Nohria: Why US Competitiveness Matters
government's sustained commitment to keeping China's economy in good health. This allows them to invest with confidence. The Chinese care about China, of course, but they are rooting for America as well.... View Details
Keywords: by Nitin Nohria
- 11 Feb 2019
- Research & Ideas
The Business of Saving the Planet
Business School alumni. Howard Stevenson discusses their pragmatic approaches to overcoming long odds. Consumers Blame Business for Global Health Problems. Can Business Become the Solution?Millions of people have been harmed by... View Details
- December 2007 (Revised July 2009)
- Case
Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?
GI has developed a revolutionary video pill for imaging the small bowel in the gastro-intestinal tract. The development has required the integration of wide variety of technologies. GI founder and CEO Gabriel Meron must determine GI's marketing strategy and prioritize... View Details
Keywords: Medical Specialties; Globalized Markets and Industries; Decisions; Technological Innovation; Marketing Strategy; Market Entry and Exit; Entrepreneurship; Health Care and Treatment; Corporate Finance; Medical Devices and Supplies Industry; Japan; United States; Europe
Isenberg, Daniel J. "Given Imaging Ltd. - First We Take Manhattan, Then We Take Berlin?" Harvard Business School Case 808-033, December 2007. (Revised July 2009.)
- 19 Mar 2008
- Research & Ideas
Finding Success in the Middle of the Market
returns on investment than those pursuing the first two strategies. The woes of once great retailers like Sears Roebuck are cited as evidence. But midfield is critical. It represents the middle of the market, to which one end of the... View Details
- 18 Dec 2007
- First Look
First Look: December 18, 2007
affects emotions. Finally, work in economics on the design of monetary policy makes several assumptions (e.g., a representative agent, a summary measure of emotions akin to utility exists and that individuals only care about income and... View Details
Keywords: Martha Lagace
- 19 Feb 2019
- First Look
New Research and Ideas, February 19, 2019
behavioral health economics, focusing on insurance markets and product markets in health care. We argue that the prevalence of choice difficulties and biases leading to mistakes in these markets establish a... View Details
Keywords: Sean Silverthorne